Covered recipient · General Payments record
PAMELA L JACKSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2023–2024
$1,229.38
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.88 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $150.11 | 17 |
| Neurocrine BioSciences, Inc. | $48.87 | 2 |
| Teva Pharmaceuticals USA, Inc. | $42.87 | 2 |
| Alkermes, Inc. | $33.05 | 2 |
| ITI, Inc. | $21.76 | 1 |
| Indivior Inc. | $17.97 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.89 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390172 | CMS |
| ABBVIE INC. | $14.71 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390174 | CMS |
| ABBVIE INC. | $6.91 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390176 | CMS |
| ABBVIE INC. | $6.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390178 | CMS |
| ABBVIE INC. | $5.56 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390180 | CMS |
| ABBVIE INC. | $11.68 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390182 | CMS |
| ABBVIE INC. | $7.85 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390184 | CMS |
| ABBVIE INC. | $11.46 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390186 | CMS |
| ABBVIE INC. | $6.14 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390188 | CMS |
| ABBVIE INC. | $22.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390190 | CMS |
| ABBVIE INC. | $10.09 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390192 | CMS |
| ABBVIE INC. | $3.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390194 | CMS |
| ABBVIE INC. | $6.33 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390196 | CMS |
| ABBVIE INC. | $7.29 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390198 | CMS |
| ABBVIE INC. | $5.97 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390200 | CMS |
| ABBVIE INC. | $4.75 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390202 | CMS |
| ABBVIE INC. | $7.86 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107390204 | CMS |
| Alkermes, Inc. | $15.93 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120522619 | CMS |
| Alkermes, Inc. | $17.12 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120522621 | CMS |
| Indivior Inc. | $17.97 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144557197 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.76 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143512658 | CMS |
| Neurocrine Biosciences, Inc. | $25.55 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150953094 | CMS |
| Neurocrine Biosciences, Inc. | $23.32 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150962428 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.25 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119102710 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.46 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151718418 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.41 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151718426 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.